{"id":"https://openalex.org/W2148653530","doi":"https://doi.org/10.1093/jnci/djq466","title":"Chemoprevention, Risk Reduction, Therapeutic Prevention, or Preventive Therapy?","display_name":"Chemoprevention, Risk Reduction, Therapeutic Prevention, or Preventive Therapy?","publication_year":2010,"publication_date":"2010-11-29","ids":{"openalex":"https://openalex.org/W2148653530","doi":"https://doi.org/10.1093/jnci/djq466","mag":"2148653530","pmid":"https://pubmed.ncbi.nlm.nih.gov/21115881"},"language":"en","primary_location":{"id":"doi:10.1093/jnci/djq466","doi":"https://doi.org/10.1093/jnci/djq466","is_oa":true,"landing_page_url":"https://doi.org/10.1093/jnci/djq466","pdf_url":"https://academic.oup.com/jnci/article-pdf/102/24/1815/7672435/djq466.pdf","source":{"id":"https://openalex.org/S98010888","display_name":"JNCI Journal of the National Cancer Institute","issn_l":"0027-8874","issn":["0027-8874","1460-2105"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JNCI Journal of the National Cancer Institute","raw_type":"journal-article"},"volume":null,"type":"editorial","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://academic.oup.com/jnci/article-pdf/102/24/1815/7672435/djq466.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060872059","display_name":"Frank Louis Meyskens","orcid":"https://orcid.org/0000-0002-8827-4334","observed_orcids":["https://orcid.org/0000-0002-8827-4334"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"F. L. Meyskens","raw_affiliation_strings":["Affiliations of authors: Department of Medicine (FLM), Department of Biological Chemistry (FLM), Department of Public Health (FLM), and Department of Epidemiology (CEM), University of California, Irvine, Irvine, CA; Chao Family Comprehensive Cancer Center, University of California, Irvine, Irvine, CA (FLM, CEM)","Affiliations of authors: Department of Medicine (FLM), Department of Biological Chemistry (FLM), Department of Public Health (FLM), and Department of Epidemiology (CEM), University of California, Irvine, Irvine, CA","Chao Family Comprehensive Cancer Center, University of California, Irvine, Irvine, CA (FLM, CEM)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Affiliations of authors: Department of Medicine (FLM), Department of Biological Chemistry (FLM), Department of Public Health (FLM), and Department of Epidemiology (CEM), University of California, Irvine, Irvine, CA; Chao Family Comprehensive Cancer Center, University of California, Irvine, Irvine, CA (FLM, CEM)","institution_ids":["https://openalex.org/I204250578"]},{"raw_affiliation_string":"Affiliations of authors: Department of Medicine (FLM), Department of Biological Chemistry (FLM), Department of Public Health (FLM), and Department of Epidemiology (CEM), University of California, Irvine, Irvine, CA","institution_ids":["https://openalex.org/I204250578"]},{"raw_affiliation_string":"Chao Family Comprehensive Cancer Center, University of California, Irvine, Irvine, CA (FLM, CEM)","institution_ids":["https://openalex.org/I204250578"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103071787","display_name":"Christine E. McLaren","orcid":"https://orcid.org/0000-0002-7932-9903","observed_orcids":["https://orcid.org/0000-0002-7932-9903"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. E. McLaren","raw_affiliation_strings":["Affiliations of authors: Department of Medicine (FLM), Department of Biological Chemistry (FLM), Department of Public Health (FLM), and Department of Epidemiology (CEM), University of California, Irvine, Irvine, CA; Chao Family Comprehensive Cancer Center, University of California, Irvine, Irvine, CA (FLM, CEM)","Affiliations of authors: Department of Medicine (FLM), Department of Biological Chemistry (FLM), Department of Public Health (FLM), and Department of Epidemiology (CEM), University of California, Irvine, Irvine, CA","Chao Family Comprehensive Cancer Center, University of California, Irvine, Irvine, CA (FLM, CEM)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Affiliations of authors: Department of Medicine (FLM), Department of Biological Chemistry (FLM), Department of Public Health (FLM), and Department of Epidemiology (CEM), University of California, Irvine, Irvine, CA; Chao Family Comprehensive Cancer Center, University of California, Irvine, Irvine, CA (FLM, CEM)","institution_ids":["https://openalex.org/I204250578"]},{"raw_affiliation_string":"Affiliations of authors: Department of Medicine (FLM), Department of Biological Chemistry (FLM), Department of Public Health (FLM), and Department of Epidemiology (CEM), University of California, Irvine, Irvine, CA","institution_ids":["https://openalex.org/I204250578"]},{"raw_affiliation_string":"Chao Family Comprehensive Cancer Center, University of California, Irvine, Irvine, CA (FLM, CEM)","institution_ids":["https://openalex.org/I204250578"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I204250578"],"apc_list":{"value":5436,"currency":"USD","value_usd":5436},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":20,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"102","issue":"24","first_page":"1815","last_page":"1817"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11306","display_name":"Nonmelanoma Skin Cancer Studies","score":0.8970000147819519,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11306","display_name":"Nonmelanoma Skin Cancer Studies","score":0.8970000147819519,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11013","display_name":"Skin Protection and Aging","score":0.08969999849796295,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.00570000009611249,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chemoprevention","display_name":"chemoprevention","score":0.9100000262260437},{"id":"https://openalex.org/keywords/non-melanoma-skin-cancer","display_name":"non-melanoma skin cancer","score":0.9490000009536743},{"id":"https://openalex.org/keywords/actinic-keratosis","display_name":"actinic keratosis","score":0.9100000262260437},{"id":"https://openalex.org/keywords/celecoxib","display_name":"celecoxib","score":0.9819999933242798},{"id":"https://openalex.org/keywords/early-carcinogenesis","display_name":"early carcinogenesis","score":0.5059999823570251},{"id":"https://openalex.org/keywords/retinoids","display_name":"retinoids","score":0.5419999957084656},{"id":"https://openalex.org/keywords/risk-reduction","display_name":"risk mitigation","score":0.4009999930858612},{"id":"https://openalex.org/keywords/prophylaxis","display_name":"prophylaxis","score":0.5659999847412109},{"id":"https://openalex.org/keywords/skin-carcinogenesis","display_name":"skin carcinogenesis","score":0.5389999747276306},{"id":"https://openalex.org/keywords/tamoxifen","display_name":"tamoxifen","score":0.4350000023841858},{"id":"https://openalex.org/keywords/raloxifene","display_name":"raloxifene","score":0.9940000176429749}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7685573101043701},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5446237921714783},{"id":"https://openalex.org/C2910086692","wikidata":"https://www.wikidata.org/wiki/Q422225","display_name":"Actinic keratoses","level":3,"score":0.5072112083435059},{"id":"https://openalex.org/C74909509","wikidata":"https://www.wikidata.org/wiki/Q10387","display_name":"Gerontology","level":1,"score":0.37856408953666687},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.35803669691085815},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.27718570828437805},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.26451385021209717},{"id":"https://openalex.org/C3019992690","wikidata":"https://www.wikidata.org/wiki/Q92767510","display_name":"Basal cell","level":2,"score":0.0756603479385376},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068579","descriptor_name":"Celecoxib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000236","descriptor_name":"Adenoma","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D002280","descriptor_name":"Basal Cell Carcinoma","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D002294","descriptor_name":"Carcinoma, Squamous Cell","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D009626","descriptor_name":"Terminology as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011315","descriptor_name":"Preventive Medicine","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":true},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016588","descriptor_name":"Anticarcinogenic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D016588","descriptor_name":"Anticarcinogenic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018890","descriptor_name":"Chemoprevention","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":true},{"descriptor_ui":"D040242","descriptor_name":"Risk Reduction Behavior","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D052246","descriptor_name":"Cyclooxygenase 2 Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D052246","descriptor_name":"Cyclooxygenase 2 Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D055623","descriptor_name":"Keratosis, Actinic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D055623","descriptor_name":"Keratosis, Actinic","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1093/jnci/djq466","doi":"https://doi.org/10.1093/jnci/djq466","is_oa":true,"landing_page_url":"https://doi.org/10.1093/jnci/djq466","pdf_url":"https://academic.oup.com/jnci/article-pdf/102/24/1815/7672435/djq466.pdf","source":{"id":"https://openalex.org/S98010888","display_name":"JNCI Journal of the National Cancer Institute","issn_l":"0027-8874","issn":["0027-8874","1460-2105"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JNCI Journal of the National Cancer Institute","raw_type":"journal-article"},{"id":"pmid:21115881","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21115881","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the National Cancer Institute","raw_type":"Comment"},{"id":"pmh:oai:escholarship.org/ark:/13030/qt8137z7rf","doi":null,"is_oa":true,"landing_page_url":"https://escholarship.org/uc/item/8137z7rf","pdf_url":null,"source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of the National Cancer Institute, vol 102, iss 24","raw_type":"article"},{"id":"pmh:oai:escholarship.org:ark:/13030/qt8137z7rf","doi":null,"is_oa":true,"landing_page_url":"https://escholarship.org/uc/item/8137z7rf","pdf_url":null,"source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of the National Cancer Institute, vol 102, iss 24","raw_type":"article"},{"id":"pmh:oai:open-archive.highwire.org:jnci:djq466v1","doi":null,"is_oa":false,"landing_page_url":"http://jnci.oxfordjournals.org/cgi/content/short/djq466v1","pdf_url":null,"source":{"id":"https://openalex.org/S4406923041","display_name":"HighWire Press Open Archive","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"TEXT"},{"id":"pmh:qt8137z7rf","doi":null,"is_oa":true,"landing_page_url":"http://www.escholarship.org/uc/item/8137z7rf","pdf_url":null,"source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Meyskens, FL; & McLaren, CE. (2010). Chemoprevention, risk reduction, therapeutic prevention, or preventive therapy?. Journal of the National Cancer Institute, 102(24), 1815 - 1817. doi: 10.1093/jnci/djq466. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/8137z7rf","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1093/jnci/djq466","doi":"https://doi.org/10.1093/jnci/djq466","is_oa":true,"landing_page_url":"https://doi.org/10.1093/jnci/djq466","pdf_url":"https://academic.oup.com/jnci/article-pdf/102/24/1815/7672435/djq466.pdf","source":{"id":"https://openalex.org/S98010888","display_name":"JNCI Journal of the National Cancer Institute","issn_l":"0027-8874","issn":["0027-8874","1460-2105"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JNCI Journal of the National Cancer Institute","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G9000877839","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA062203","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2148653530.pdf","grobid_xml":"https://content.openalex.org/works/W2148653530.grobid-xml"},"referenced_works_count":22,"referenced_works":["https://openalex.org/W8856860","https://openalex.org/W65748319","https://openalex.org/W1224318197","https://openalex.org/W1985920704","https://openalex.org/W1988783822","https://openalex.org/W2006632552","https://openalex.org/W2010899039","https://openalex.org/W2053419780","https://openalex.org/W2077277471","https://openalex.org/W2097235831","https://openalex.org/W2105800318","https://openalex.org/W2106096689","https://openalex.org/W2114503152","https://openalex.org/W2133470612","https://openalex.org/W2138381757","https://openalex.org/W2143201905","https://openalex.org/W2145145182","https://openalex.org/W2151849899","https://openalex.org/W2169449395","https://openalex.org/W2204525506","https://openalex.org/W2319872820","https://openalex.org/W2322868828"],"related_works":["https://openalex.org/W2138381757","https://openalex.org/W2155730680","https://openalex.org/W7100467885","https://openalex.org/W7128644465","https://openalex.org/W65748319","https://openalex.org/W2396765475","https://openalex.org/W1992768845","https://openalex.org/W2334817162","https://openalex.org/W4385346499","https://openalex.org/W7126118085"],"abstract_inverted_index":{"In":[0],"this":[1,258,275,442,693,830],"issue":[2,199,259,276],"of":[3,17,26,52,61,84,119,139,145,151,213,215,263,270,283,301,321,335,354,398,407,441,447,465,468,493,501,516,524,539,550,567,573,604,613,634,660,689,703,723,740,773,800,810,836,844,862,913,916,925,973,987,997,1013,1021],"the":[4,50,59,68,82,111,137,148,166,187,211,216,261,268,284,298,336,351,365,405,418,453,466,491,499,509,522,540,543,563,568,581,586,589,601,632,649,653,658,683,687,699,721,736,770,798,834,837,842,893,911,914,923,926,931,951,958,964,969,985,995,1006,1011,1019],"Journal,":[5],"Elmets":[6,288,790],"et":[7,289,791],"al.":[8,290,792],"(":[9,190,230,278,346,410,433,476,486,503,534,546,677,731,784,847,906,942,1031],"1":[10,547],")":[11,505,548,733,944,1033],"report":[12],"a":[13,18,76,132,292,343,383,495,570,610,621,752,761,803,823,883,939],"randomized":[14],"placebo-controlled":[15],"trial":[16,285,443,520,545,625,654],"moderate":[19,158,779],"dose":[20,650,754],"(ie,":[21,324],"200":[22],"mg":[23],"twice":[24],"daily)":[25],"celecoxib":[27,485,690],"vs":[28,606],"placebo":[29],"in":[30,81,136,155,208,220,229,364,421,463,479,490,498,542,553,631,706,755,769,776,897,950],"patients":[31,156,551,777,1022],"who":[32,852,1023],"have":[33,178,248,645,822,871],"10\u201340":[34],"actinic":[35,54,62,311],"keratoses":[36,55,63],"and":[37,95,105,122,141,170,240,243,265,306,356,378,471,518,549,598,657,709,820,933,945,982,992,1034,1043],"Fitzpatrick":[38],"sun-reactive":[39],"skin":[40,87,140,153,202,315,327,449],"types":[41],"I,":[42],"II,":[43],"or":[44,617,749,817,859,868,890],"III.":[45],"The":[46,281,514,787,976],"primary":[47],"outcome":[48],"was":[49,330,455,506,511,651,655],"number":[51,60,83,500,1020],"new":[53,408,611,622],"after":[56,452,508,673],"treatment.":[57],"Although":[58,936],"did":[64],"not":[65,179,196,251,415,643],"differ":[66],"between":[67,110],"two":[69,716],"study":[70,112,788],"arms,":[71],"an":[72,198,614,745,899],"exploratory":[73],"analysis":[74,334],"demonstrated":[75,462,527,626],"statistically":[77,394,628],"significant":[78,629],"time-dependent":[79],"decrease":[80,497],"all":[85],"nonmelanoma":[86,152,201,314,448],"cancers,":[88],"including":[89,103],"both":[90,532,930],"basal":[91],"cell":[92,97],"carcinomas":[93,98],"(BCCs)":[94],"squamous":[96],"(SCCs).":[99],"Adverse":[100],"event":[101],"rates,":[102],"serious":[104,635],"cardiovascular":[106,636,661,747,845],"events,":[107,425],"were":[108,304],"indistinguishable":[109],"arms.":[113],"What":[114,680],"are":[115,430],"we":[116,806,821,855],"to":[117,159,313,328,339,369,669,725,744,765,808,909,960,979,983,1027],"make":[118],"these":[120,172,249],"findings,":[121],"how,":[123],"if":[124],"at":[125,157,297,778,879],"all,":[126],"should":[127,578,596,681,1002,1017],"they":[128],"guide":[129],"us":[130],"toward":[131],"future":[133],"for":[134,147,183,200,210,267,521,531,609,620,686,701,781,797,826,841,882,903,957,966,994,1000,1010],"chemoprevention":[135,222,384,392,917],"management":[138,843,1012],"other":[142,554,711,758],"cancers?":[143],"Proof":[144],"principle":[146],"pharmacological":[149],"prevention":[150,212,269,467,482,523,867,889,905],"cancer":[154,203,272,450,526,783,904,1001],"high":[160,880,1051],"risk":[161,565,659,700,771,780,813,827,881,990,998],"has":[162,223,273,460,918],"been":[163,180,252,461,646,920],"established":[164],"over":[165],"past":[167],"25":[168],"years,":[169],"yet":[171],"interventions":[173,250,861],"(retinoids,":[174],"difluoromethylornithine,":[175],"low-fat":[176],"diet)":[177],"consistently":[181],"adopted":[182],"patient":[184],"care":[185],"by":[186,287,382,789,922,929],"oncologic":[188,934],"community":[189],"2\u20137":[191],").":[192,280,437,536,679,786,849],"This":[193,594,624,1015],"phenomenon":[194,459,595],"is":[195,205,387,414,444,583,938,946,955],"just":[197],"but":[204,400],"also":[206,919],"true":[207],"general":[209],"three":[214],"four":[217],"major":[218,352,717],"cancers":[219,473],"which":[221,413],"produced":[224],"convincingly":[225],"positive":[226],"results":[227,282],"[reviewed":[228],"8":[231],")].":[232],"These":[233],"include":[234],"colorectal":[235,480,774,782],"(adenomas),":[236],"prostate":[237],"(second":[238],"malignancies),":[239],"breast":[241,271,525],"(primary":[242],"second":[244,469],"malignancies)":[245],"cancers.":[246],"Why":[247],"adopted?":[253],"A":[254,332,457],"recent":[255],"commentary":[256],"on":[257,319,404,877],"regarding":[260],"use":[262,751,924],"tamoxifen":[264],"raloxifene":[266],"covered":[274],"well":[277],"9":[279,1032],"reported":[286],"highlight":[291],"central":[293],"message":[294],"that":[295,349,389,692,729,735,763,972],"lesions":[296,323],"late":[299,357],"stage":[300],"cutaneous":[302],"carcinogenesis":[303,341,358,705],"treated":[305],"prevented":[307],"from":[308,325,664,963],"progressing":[309],"(from":[310],"keratosis":[312],"cancer).":[316],"No":[317],"effect":[318,403],"progression":[320,702,1026],"earlier":[322],"photo-damaged":[326],"AK)":[329],"demonstrated.":[331],"thoughtful":[333],"issues":[337,796],"related":[338,368],"early":[340,355,363],"offers":[342],"possible":[344],"explanation":[345],"10":[347],"),":[348,412,478,488,908],"is,":[350],"driver(s)":[353],"may":[359,853],"be":[360,682,766,887,961,980,1003],"different":[361,432],"and,":[362,489],"process,":[366],"more":[367],"host":[370],"cells":[371],"than":[372],"altered":[373],"tumor":[374],"genomics":[375],"per":[376],"se,":[377],"hence":[379],"affected":[380],"differentially":[381],"drug.":[385],"It":[386],"interesting":[388],"difluoromethyornithine,":[390],"another":[391],"compound,":[393],"significantly":[395],"reduced":[396],"development":[397],"BCC":[399],"had":[401],"no":[402,607,627],"incidence":[406],"SCC":[409],"6":[411],"surprising":[416],"because":[417,648,829],"mechanisms":[419],"involved":[420],"their":[422],"underlying":[423],"carcinogenic":[424],"although":[426],"perhaps":[427],"partially":[428],"shared,":[429],"clearly":[431,697],"11":[434],",":[435],"12":[436],"Another":[438],"striking":[439],"feature":[440],"persistent":[445],"suppression":[446],"even":[451],"medication":[454,510],"stopped.":[456,512],"similar":[458],"trials":[464,483,557],"head":[470],"neck":[472],"with":[474,484,757,1039,1049],"retinoids":[475],"13":[477],"adenoma":[481],"14":[487],"case":[492],"calcium,":[494],"further":[496],"adenomas":[502,775],"15":[504],"observed":[507],"Recently,":[513],"Study":[515],"Tamoxifen":[517],"Raloxifene":[519],"prolonged":[528],"beneficial":[529],"effects":[530,663,739],"drugs":[533],"16":[535],"Long-term":[537],"follow-up":[538],"cohort":[541],"current":[544],"enrolled":[552],"preventive":[555,815],"therapy":[556],"will":[558],"provide":[559],"important":[560,795],"information":[561],"about":[562,674],"relative":[564],"benefit":[566,587],"agent,":[569,900],"key":[571],"element":[572],"regulatory":[574,602,895],"assessment.":[575],"Because":[576],"toxicity":[577],"diminish":[579],"when":[580],"drug":[582,696],"discontinued":[584],"while":[585],"continues,":[588],"benefit\u2013risk":[590],"ratio":[591],"increases":[592],"markedly.":[593],"markedly":[597,671],"positively":[599],"influence":[600],"decision":[603],"\u201cgo":[605],"go\u201d":[608],"indication":[612],"\u201cold":[615],"drug\u201d":[616],"initial":[618],"approval":[619],"agent.":[623],"differences":[630],"occurrence":[633],"adverse":[637],"events;":[638],"however,":[639],"such":[640],"events":[641],"would":[642],"necessarily":[644],"expected":[647],"moderate,":[652],"short,":[656],"toxic":[662,974],"COX-2":[665,741],"selective":[666],"inhibitors":[667,742],"seems":[668],"increase":[670],"only":[672,1044],"12\u201318":[675],"months":[676],"17":[678,732],"next":[684],"steps":[685],"investigation":[688],"given":[691],"widely":[694],"used":[695],"reduces":[698],"late-stage":[704],"skin,":[707],"colon,":[708],"probably":[710],"organ":[712],"sites?":[713],"We":[714],"propose":[715],"approaches:":[718],"1)":[719],"lower":[720,753],"frequency":[722],"administration":[724],"once":[726],"daily,":[727],"considering":[728],"meta-analysis":[730],"suggests":[734],"continuous":[737],"suppressive":[738],"led":[743],"increased":[746],"risk,":[748],"2)":[750],"combination":[756],"proven":[759],"compounds,":[760],"strategy":[762],"appears":[764],"highly":[767],"effective":[768],"reduction":[772,828,996],"18":[785],"raises":[793],"additional":[794],"field":[799],"\u201cchemoprevention.\u201d":[801],"From":[802],"clinical":[804],"viewpoint,":[805],"prefer":[807],"think":[809],"\u201cchemoprevention\u201d":[811,928,937],"as":[812,989],"reduction,":[814,991],"therapy,":[816],"therapeutic":[818,839,1008],"prevention,":[819],"strong":[824],"preference":[825],"terminology":[831,977],"fits":[832],"into":[833,1005],"nosology":[835],"long-standing":[838],"paradigm":[840,1009],"diseases":[846],"19":[848],"For":[850],"those":[851],"object,":[854],"ask:":[856],"\u201cAre":[857],"surgery":[858,875],"ablative":[860],"precancers":[863],"(and":[864],"localized":[865],"cancers)":[866],"treatment?\u201d":[869,891],"Others":[870],"asked:":[872],"\u201cShould":[873],"prophylactic":[874],"performed":[876],"individuals":[878],"specific":[884],"genetic":[885],"disease":[886,1025],"considered":[888],"Notwithstanding":[892],"enormous":[894],"challenges":[896],"bringing":[898],"particularly":[901],"one":[902],"20":[907],"market,":[910],"perception":[912],"effectiveness":[915],"marginalized":[921],"term":[927,941],"public":[932],"profession.":[935],"revered":[940],"21":[943],"still":[947],"appropriate":[948],"usage":[949],"preclinical":[952],"setting,":[953],"it":[954,967],"time":[956],"word":[959],"retired":[962],"clinic":[965],"conveys":[968],"wrong":[970],"message,":[971],"chemotherapy.":[975],"needs":[978],"updated":[981],"enter":[984],"mainstream":[986],"medicine":[988],"therapies":[993],"factors":[999],"integrated":[1004],"broader":[1007],"cancer.":[1014],"approach":[1016],"reduce":[1018],"experience":[1024],"overt":[1028],"advanced":[1029],"malignancy":[1030],"then":[1035],"require":[1036],"high-end":[1037],"testing":[1038],"increasingly":[1040],"expensive":[1041],"technologies":[1042],"incrementally":[1045],"better":[1046],"tertiary":[1047],"treatment":[1048],"very":[1050],"price":[1052],"tags.":[1053]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}